SCHEMBL9998277

SCHEMBL9998277

CC/C(=C\c1cccc(C(C)(C)C)c1)COC(C)=O

nearest known ligand 0.38

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ACHE P22303 3/20 0.38
TRPV1 Q8NER1 1/20 0.36
CYP26B1 Q9NR63 2/20 0.36
HDAC4 P56524 1/20 0.35
HDAC2 Q92769 1/20 0.35
HDAC8 Q9BY41 1/20 0.35
HMGCR P04035 1/20 0.35
CYP26A1 O43174 1/20 0.34
GLO1 Q04760 1/20 0.34
HTT P42858 1/20 0.34
RXRA P19793 1/20 0.34
RXRB P28702 1/20 0.34
MAPT P10636 2/20 0.33
PDCD1 Q15116 1/20 0.33
CD274 Q9NZQ7 1/20 0.33
MEN1 O00255 1/20 0.33
KMT2A Q03164 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9998278 1.00 ACHE (0.38) ACHETRPV1CYP26B1HDAC4HDAC2
SCHEMBL9998471 0.90 ACHE (0.36) ACHETRPV1CYP26B1HDAC4HDAC2
SCHEMBL9998469 0.90 ACHE (0.36) ACHETRPV1CYP26B1HDAC4HDAC2
SCHEMBL9998423 0.85 CYP26B1 (0.41) ACHECYP26B1CYP26A1RXRARXRB
SCHEMBL9998428 0.85 CYP26B1 (0.41) ACHECYP26B1CYP26A1RXRARXRB
SCHEMBL9998040 0.85 ACHE (0.40) ACHETRPV1CYP26B1HDAC4HDAC2
SCHEMBL9998039 0.85 ACHE (0.40) ACHETRPV1CYP26B1HDAC4HDAC2
SCHEMBL9998124 0.83 CYP1A2 (0.41) TRPV1MAPTMEN1KMT2A
SCHEMBL9998126 0.83 CYP1A2 (0.41) TRPV1MAPTMEN1KMT2A
SCHEMBL9997395 0.82 LMNA (0.41) GLO1MAPTPDCD1CD274MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8558012-B2 2-fluoro-1,3-benzodithiol 1,1,3,3-tetraoxide derivative, production method thereof, and production method of monofluoromethyl group-containing compound using the same NAGOYA INSTITUTE OF TECHNOLOGY (JP) 2013-10-15 US disclosed
US-20110319637-A1 2-FLUORO-1,3-BENZODITHIOL 1,1,3,3-TETRAOXIDE DERIVATIVE, PRODUCTION METHOD THEREOF, AND PRODUCTION METHOD OF MONOFLUOROMETHYL GROUP-CONTAINING COMPOUND USING THE SAME NAGOYA INSTITUTE OF TECHNOLOGY (JP) 2011-12-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110319637-A1 2-FLUORO-1,3-BENZODITHIOL 1,1,3,3-TETRAOXIDE DERIVATIVE, PRODUCTION METHOD THEREOF, AND PRODUCTION METHOD OF MONOFLUOROMETHYL GROUP-CONTAINING COMPOUND USING THE SAME CBR1, CYP1B1, CYP2F1 ACHE 3512/4885TRPV1 2954/4885CYP26B1 241/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.